Treatment of peripheral arterial disease using stem and progenitor cell therapy Holger Lawall, MD, Peter Bramlage, MD, PhD, Berthold Amann, MD Journal of Vascular Surgery Volume 53, Issue 2, Pages 445-453 (February 2011) DOI: 10.1016/j.jvs.2010.08.060 Copyright © 2011 Society for Vascular Surgery Terms and Conditions
Fig 1 Schematic diagram of putative events in the angiogenic process. EC, Endothelial cell. (Figure reproduced with permission from Lawall et al.4) Journal of Vascular Surgery 2011 53, 445-453DOI: (10.1016/j.jvs.2010.08.060) Copyright © 2011 Society for Vascular Surgery Terms and Conditions
Fig 2 Schematic diagram of putative events in the arteriogenic process. EC, Endothelial cell; GM-CSF, granulocyte-macrophage colony-stimulating factor; MCP-1, monocyte chemoattractant protein-1; PDGF, platelet derived growth factor; SMC, smooth muscle cell; TNF-α, tumor necrosis factor-α. (Figure reproduced with permission from Lawall et al.4) Journal of Vascular Surgery 2011 53, 445-453DOI: (10.1016/j.jvs.2010.08.060) Copyright © 2011 Society for Vascular Surgery Terms and Conditions